JNJ

Johnson & Johnson's New Diabetes Drug And Its Competitors
Seeking Alpha
Tue, 04/2/13 - 09:52 am
JNJ
diabetes
Invokana
Merck
Januvia
Byetta
Bristol-Myers Squibb
Four Factors Driving Amgen's Stock Price To $102
Seeking Alpha
Mon, 04/1/13 - 10:38 am
Amgen
AbbVie
Bristol-Myers Squibb
JNJ
Merck
Eli Lilly
Pfizer
Diabetes Drug Could Rake Hundreds of Millions for J&J
Wall St. Cheat Sheet
Mon, 04/1/13 - 10:31 am
JNJ
Invokana
diabetes
FDA OKs first-of-a-kind diabetes drug from J&J
Yahoo/AP
Sat, 03/30/13 - 11:01 am
JNJ
diabetes
Invokana
type 2 diabetes
Celgene's Star Drug Revlimid And Its Competitors
Seeking Alpha
Sat, 03/30/13 - 10:57 am
Celgene
Revlimid
Multiple Myeloma
JNJ
Velcade
AbbVie
Bristol-Myers Squibb
elotuzumab
Johnson & Johnson Waits for FDA Ruling on new Diabetes Drug
Motley Fool
Fri, 03/29/13 - 10:49 am
FDA
JNJ
diabetes
Invokana
How Much Will FDA Action On Invokana Affect Johnson And Johnson's Revenue And Stock Price?
Seeking Alpha
Thu, 03/28/13 - 10:23 am
JNJ
FDA
Invokana
AstraZeneca
Bristol-Myers Squibb
Merck
Sanofi
Novo Nordisk
Novartis
Johnson & Johnson's OneTouch Proves Not All Recalls Are Alike
Motley Fool
Tue, 03/26/13 - 10:50 am
recalls
LifeScan
JNJ
blood glucose monitoring
J&J recalling more than 2 mln blood glucose meters worldwide
Reuters
Mon, 03/25/13 - 12:17 pm
JNJ
LifeScan
recalls
blood glucose monitoring
2 Can't-Miss FDA Rulings Next Week
Motley Fool
Sun, 03/24/13 - 12:27 pm
JNJ
Invokana
type 2 diabetes
diabetes
pulmonary arterial hypertension
Treprostinil
Can Johnson & Johnson Turn Around This Lagging Business?
Motley Fool
Sun, 03/24/13 - 12:18 pm
JNJ
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Sat, 03/23/13 - 10:06 am
Repros Therapeutics
JNJ
Bristol-Myers Squibb
Watson Pharmaceuticals
Europe and US Diverge On Two New Drugs
Forbes
Sat, 03/23/13 - 09:41 am
Xarelto
mipomersen
JNJ
Genzyme
J&J's answer to Botox may escalate war on wrinkles
Reuters
Fri, 03/22/13 - 10:53 am
JNJ
Botox
Allergan
Mentor
Dysport
Xeomin
Bayer, J&J’s Xarelto Wins EU Backing for Expanded Use
Bloomberg
Fri, 03/22/13 - 10:46 am
Bayer
JNJ
Europe
Xarelto
bloodthinners
Drug maker JNJ: $327M deceptive marketing penalty should be invalidated because no one in SC hurt
Yahoo/AP
Fri, 03/22/13 - 10:40 am
JNJ
Janssen
South Carolina
Supreme Court to Consider Frozen Funds of Former J&J Sales Representative
NASDAQ.com
Wed, 03/20/13 - 12:14 pm
Supreme Court
JNJ
drug reps
Genmab Rises as Nordea Says Bet on Cancer Drug: Copenhagen Mover
Bloomberg
Wed, 03/20/13 - 12:09 pm
Genmab
JNJ
daratumumab
Multiple Myeloma
Drug-Resistant Tuberculosis Spreads as $1.6 Billion Needed
Bloomberg
Mon, 03/18/13 - 10:47 am
drug-resistant tuberculosis
Sirturo
JNJ
Dow 30 Healthcare Stock Buzz This Week
Wall Street Cheat Street
Sun, 03/17/13 - 11:47 am
JNJ
Merck

Pages